News
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...
Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...
Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...
Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...
Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...
Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the ...
Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...
Now Google’s DeepMind division says it’s made a leap in trying to understand the code with AlphaGenome, an AI model that ...
Google DeepMind won bragging rights that its competitors in the field of AI could only dream of. A share of the 2024 Nobel Prize in Chemistry was awarded to Demis Hassabis, its CEO, and John Jumper, ...
Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results